Skip to main content
. 2021 Apr 6;137(20):2838–2847. doi: 10.1182/blood.2020010529

Table 7.

ATE, VTE, mortality, MB, and other postdischarge outcomes

n (%)
VTE 76 (1.55)*
 DVT 44 (0.90)
 PE 42 (0.85)
 Splanchnic vein thrombosis 2 (0.04)
 Other vein thrombosis 3 (0.06)
Arterial thromboembolism 84 (1.71)*
 Stroke 22 (0.45)
 MI 24 (0.49)
 Non-MI coronary revascularization 6 (0.12)
 Major adverse limb event 26 (0.53)
 Systemic embolism 16 (0.33)
All-cause mortality 237 (4.83)
MB 85 (1.73)
Other outcomes
 Rehospitalization 759 (15.5)
 ICU admission 230 (4.69)
 Heart failure exacerbation 63 (1.28)
 Atrial fibrillation/flutter 22 (0.45)
 Interstitial lung disease 26 (0.53)
 Myocarditis 1 (0.02)
 Acute respiratory distress syndrome 113 (2.3)
*

Patients may have multiple events.